• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTHROSURFACE, INC. ARTHROSURFACE TOEMOTION; ARTHROSURFACE® TOTAL TOE - PROXIMAL PHALANX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTHROSURFACE, INC. ARTHROSURFACE TOEMOTION; ARTHROSURFACE® TOTAL TOE - PROXIMAL PHALANX IMPLANT Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problems Loss of Range of Motion (2032); Joint Swelling (2356); Inadequate Pain Relief (2388)
Event Type  Injury  
Manufacturer Narrative
The patient received toe-motion implant in (b)(6) 2017.Per the rep who attended the revision case, the reported pain, swelling and loss of range of motion were attributed to the loosening of phalangeal component.Root cause was unable to be determined as the device was not returned.The device history records (dhrs) of the implant lots in questions were reviewed and noted that all parts were built to specification.Non-conforming parts have been properly identified and segregated during the inspection process.The instructions for use (ifu) document states that reported events can occur, and all risks are addressed in the risk documentation as a apart of the design control.Several factors such as stress/ physical loads on the implants, vascularity of the implantation site, surgical techniques employed during implantation, patient factors (such as age, current state of the immune system, bone quality, and sensitivity to device materials), and patient post-op compliance to rehabilitation procedures etc., can have impact on the functional effectiveness of the implanted devices.The implant materials and combinations have decades of history for use in joint replacement applications.Also, the implant materials have been evaluated for biocompatibility to demonstrate safety for intended purposes.If additional relevant information is received, information will be reviewed and complaint file will be amended accordingly.The patient was revised to a fusion and all arthrosurface devices have been explanted.Following is the information of implants in question.Part # 9p15-s180-w, lot # 75af2810, mfg.Date: 05/06/2016, exp.Date: 05/06/2021.Part # 9p15-pb01-w, lot # 75cf3110, mfg.Date: 05/11/2016, exp.Date: 05/06/2023.
 
Event Description
A total toe patient was revised due to pain, swelling and loss of range of motion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTHROSURFACE TOEMOTION
Type of Device
ARTHROSURFACE® TOTAL TOE - PROXIMAL PHALANX IMPLANT
Manufacturer (Section D)
ARTHROSURFACE, INC.
28 forge parkway
franklin MA 02038
Manufacturer (Section G)
PRIMO MEDICAL GROUP
75 mill st
stoughton, ma 02072
Manufacturer Contact
phani puppala
28 forge parkway
franklin, ma 02038
5085203003
MDR Report Key7927315
MDR Text Key122374741
Report Number3004154314-2018-00017
Device Sequence Number1
Product Code LZJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K132496
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 09/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/03/2018
Initial Date FDA Received10/02/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-